While many advocate that oversight of AI analyses of lab data be handled through CLIA, some stakeholders say that FDA should play a role.

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/trkb23/laboratory) has announced the addition of the "Laboratory Information ...

Innovaccer Inc., a leading healthcare AI company, today announced that Beckman Coulter Diagnostics, a global clinical diagnostics leader and a Danaher company, has selected Gravity, Innovaccer’s ...

“WAM v5.0 includes an extended delta and previous checking module that goes beyond the clinical laboratory's traditional delta checking by adding the ability to 'look back' and determine the absence ...

The analytics & reporting segment holds a significant market share in the laboratory software market. The software segment has the fastest growth rate in the laboratory software market by component.

Mayo Clinic and National Decision Support Company announced on Tuesday a new offering that enables physicians to access clinical guidance about laboratory tests at the point of care. The new offering ...

Clinical Trial Central Lab Services Market Overview: The global clinical trial central lab services market is expected to expand at a CAGR of 7% over the forecast period. Growth is being fueled by the ...

Physicians choose medicine to care for patients rather than to spend their evenings catching up on documentation or chasing ...

Clinical Laboratory Improvement Amendments, or CLIA, are a high bar as set by the US Government under Clinical Laboratory Improvement Amendment 42 CFR 493.1253 to obtain and maintain quality ...